6Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly [ J ]. Expert Opin Drug Saf, 2014 , 13 (1) :57-65.
7Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting [J]. J Am Geriatr Soc,2004,52(8) :1349-1354.
8Kim HA, Shin JY, Kim MH, et al. Prevalence and predictors of polypharmaey among Korean elderly [ J ]. PLoS One, 2014, 9 (6) : e98043.